Other reports demonstrated that the expression of ANXA8 is significantly increased in breast cancer 17-19, pancreatic cancer 20-22, ovarian cancer 23 and cholangiocarcinoma 24. Here, ANXA8 is linked to familial pancreatic carcinoma.